Phillips, JB;
(2021)
'EngNT' - Engineering live neural tissue for nerve replacemen.
Emerging Topics in Life Sciences
10.1042/ETLS20210085.
Preview |
Text
etls-2021-0085c.pdf - Published Version Download (4MB) | Preview |
Abstract
Peripheral nerve injury can result in severe long-term disability and current clinical approaches for repairing large gaps rely on the nerve autograft. Engineered Neural Tissue (EngNT) has been developed to provide living aligned therapeutic cells in a stabilised collagen hydrogel, mimicking the key features of the autograft. This Perspective article will introduce the field and discuss the current stage of translation, highlighting the key opportunities for commercial and clinical development.
Type: | Article |
---|---|
Title: | 'EngNT' - Engineering live neural tissue for nerve replacemen |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1042/ETLS20210085 |
Publisher version: | http://dx.doi.org/10.1042/ETLS20210085 |
Language: | English |
Additional information: | © 2021 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND). |
Keywords: | advanced therapy, neuroregeneration, regenerative medicine, tissue engineering |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10132089 |
Archive Staff Only
View Item |